- EvokAI Creative Labs (TSXV:OKAI) completes acquisition of Rehaboo Oy
- The acquisition will strengthen the company’s goal of revolutionizing the healthcare industry
- Integrating Rehaboo’s technology with EvokAI will allow for new avenues of innovation in the gamification era
- Shares of EvokAI Creative Stocks (TSXV:OKAI) are unchanged at C$2.11
EvokAI (TSXV:OKAI) has officially closed its acquisition of Rehaboo Oy, an artificial intelligence company that has developed a physical gamification platform.
The company stated in a news release the acquisition of Rehaboo Oy will strengthen opportunities for new avenues of innovation and disruption in the gamification era.
Gamification is a technology used to enhance people’s engagement in non-game contexts by using tools similar to actual games.
“With the acquisition of Rehaboo, a trailblazing company at the forefront of leveraging gamification to fight inactivity, we continue to strengthen our mission to revolutionize the healthcare industry and empower individuals to adopt healthier lifestyles,” Alejandro Antalich, CEO of EvokAI Creative Labs, said in a statement.
“By combining resources, knowledge, and expertise, we are expanding our reach in the medtech industry, accelerating the development and deployment of our gamification platform on a global scale, enabling millions of individuals to take control of their brain and body health, regardless the income level due to the unique approach that transforms the human body into a game controller.”
Rehaboo’s cloud-based gaming platform analyzes, learns, improves and predicts movement and cognitive activation.
The technology is being used in hospitals and care homes as well as a home care solution in Finland and Denmark. It is also being used in research pilot projects in Singapore and Norway.
With headquarters in Vancouver, B.C., EvokAI is a med-tech AI company developing technologies for the healthcare industry.
The company’s AI algorithms are intended for hospitals, private clinics, research institutions, pharmaceutical companies, medical professionals and patients among many others.
Shares of EvokAI (OKAI) are unchanged at C$2.11.
Find out what everybody’s saying about this stock on the EvokAI Creative Stock Forum, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.